Cardiff Lexington Q2 FY26 net loss more than doubles to $2.48 million; revenue falls 22.57% to $2.16 million

• Cardiff Lexington posted a Q2 net loss of $2.48 million, more than doubled from a year earlier.
• Revenue fell 22.57% to $2.16 million year over year, on a lower implicit realization rate of patient case claim settlements.
• Operating results swung to a $544,643 loss from operating income, as selling, general and administrative costs climbed 37.72% to $1.36 million.
• For the six months, net loss widened to $5.57 million, while revenue dropped 23.19% to $4.38 million.
• Cash totaled $217,654 at June 30; July 13 brought a common stock purchase issuing 166,667 commitment shares and 20,619 shares for $30,000.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cardiff Lexington Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001683168-26-006232), on August 12, 2026, and is solely responsible for the information contained therein.